Educational comparison only · Not medical advice · Scores are not for sale

GLP1 Ranked

RankingsRanking

Best GLP-1 Telehealth Providers (2026): Ranked by Total Monthly Cost

We compared Sesame, Ro, WeightWatchers Med+ and Hims & Hers on total monthly cost, brand-name drugs and insurance help. See who we rejected and why.

By Cora Burke

Abstract telehealth scorecard in clinical teal listing transparency checks, with no provider logos.

Medical disclaimer: Not medical advice. Telehealth is still medical care: a licensed clinician must decide if a prescription is appropriate. We do not provide diagnoses or dosing. Questions or corrections: [email protected]

Prices on this page are as of October 27, 2026 and change often. Items we couldn’t confirm are marked UNVERIFIED.

Quick answer: our ranking at a glance

The drug costs the same almost everywhere. Your real monthly bill is membership plus medication, and the membership is where providers differ.

Ro, Hims & Hers, WeightWatchers Med+ and Sesame all show the same manufacturer cash prices: the Wegovy pill from $149, the Wegovy pen from $199, and Zepbound from $299 (all as of Oct 27, 2026). Starting-dose total for the pill: about $208 a month at Sesame on its annual plan, $223 at Ro or WeightWatchers on 12-month plans, and $298 at Hims & Hers. That’s our arithmetic from published rates, shown in the cost table below.

Rank Provider Who it suits Membership (as of Oct 27, 2026) Lowest cash med price shown (as of Oct 27, 2026) Insurance help Score /100
1 Sesame Cash payers who want the lowest membership and will pick their own provider $59/mo annual · $99/mo month-to-month Wegovy pill and Foundayo from $149 Doesn’t bill insurance for care; its providers help with prior authorization if your plan covers the drug (Sesame’s own FAQ) 86
2 Ro (Ro Body) Brand-only shoppers who want a named pharmacy and a coverage check $39 first month, then $74/mo annual prepay or $149/mo monthly Wegovy pill from $149 Free insurance check and concierge for pens; membership itself is cash-only 85
3 WeightWatchers Med+ People who want an explicit “FDA-approved only” promise and will commit 6–12 months $25 first month, then $74/mo (12-month) or $84/mo (6-month) Oral GLP-1s from $149 Insurance coordinator helps with prior authorizations (commercial plans only) 84
4 Hims & Hers App-first users who value 24/7 messaging and accept the highest membership $39 first month, then $149/mo Wegovy pill and Foundayo from $149 None: Hims’ own help page says it can’t accept insurance (updated Feb 16, 2026) 78

Not ranked (disqualified): Found, Noom Med and Mochi. They steer their cheapest plans toward compounded drugs. Why below.

  • First-year membership alone ranges from about $708 to about $1,678, a 2.4× gap for the same drugs (as of Oct 27, 2026; our arithmetic, see table notes).
  • The top three are within two points. Treat #1–#3 as a near-tie and pick on membership price, insurance and cancellation terms.
  • One flag on #4: FDA sent Hims & Hers a warning letter on Sept 9, 2025 over its compounded semaglutide claims, and it still offers compounded semaglutide in limited cases. Details in its section.
A stethoscope resting on a notebook beside a laptop
Photo by Abdulai Sayni on Unsplash

How we ranked these providers

Same site rubric, 100 points: evidence/label fit 25 · price transparency 20 · total cost realism 15 · care quality 15 · safety/authenticity 15 · UX/support 10. The full method is on our methodology page.

Provider Label fit /25 Price clarity /20 Real cost /15 Care /15 Safety /15 UX /10 Total
Sesame 24 18 13 11 12 8 86
Ro 23 18 12 11 14 7 85
WeightWatchers Med+ 24 17 10 12 13 8 84
Hims & Hers 20 16 11 11 12 8 78
Found (DQ) 9 14 8 9 5 7 52
Noom Med (DQ) 9 10 9 9 6 7 50
Mochi (DQ) 8 14 8 9 4 7 50

Hard disqualifiers (any one removes a provider from the ranking):

  1. A default funnel to compounded product while advertising brand names.
  2. Claims that compounded drugs are “generic Ozempic/Wegovy” or “FDA approved.”
  3. No identifiable dispensing pharmacy.

Disqualified providers’ scores are for reference only.

What these scores are, and aren’t: They are editorial judgments built from each provider’s published pages and terms, captured Oct 27, 2026. We did not place orders, test response times, or audit reviews. We don’t quote Reddit or review-site threads, and no score depends on them. UX/support and care-quality scores are the softest numbers here. We did not check every provider against FDA’s warning-letter database (UNVERIFIED), except where noted below.

A calculator and pen resting on a sheet of paper
Photo by Aaron Lefler on Unsplash

What a GLP-1 telehealth program really costs (membership + medication)

You pay two bills: a membership or care fee, and the medication, billed separately. Medication cash prices are set by the manufacturers (NovoCare and LillyDirect), so they match across these providers. For the manufacturer baselines, see our GLP-1 cost and pricing guide.

Starting-dose monthly total (membership + first-dose medication, as of Oct 27, 2026)

Plan Membership /mo (as of Oct 27, 2026) + Wegovy pill 1.5 mg, from $149 (as of Oct 27, 2026) + Zepbound 2.5 mg, from $299 (as of Oct 27, 2026)
Sesame, annual $59 $208 $358
Sesame, 6-month (derived) $69 $218 $368
Sesame, 3-month (derived) $79 $228 $378
Sesame, month-to-month $99 $248 $398
WeightWatchers, 12-month, $49 promo (ends Nov 2, 2026) $49 $198 $348
Ro, annual prepay $74 $223 $373
WeightWatchers, 12-month $74 $223 $373
Ro, 6-month prepay $89 $238 $388
WeightWatchers, 6-month $84 $233 $383
Ro, 3-month prepay $99 $248 $398
Ro, monthly $149 $298 $448
Hims & Hers, monthly (no prepaid plan found) $149 $298 $448

Our arithmetic from published rates. Annual and 6/12-month plans are prepaid or committed; Hims & Hers lists none that we found (UNVERIFIED). “From” prices apply to the lowest dose. Sesame’s 6- and 3-month rows are derived from the savings Sesame states against its $99 monthly plan ($180 per 6 months and $60 per 3 months), so treat them as our arithmetic, not a posted price. The WeightWatchers $49 row is a limited promo for new or rejoining Med+ members paying cash for medication, and it ends Nov 2, 2026 (WW self-pay page). First-month promos aren’t included: Sesame none advertised, Ro $39 (refunded if you’re ineligible), WeightWatchers $25, Hims & Hers $39. Hims’ own page confirms its “from” prices cover medication only. Labs and other fees: see each provider’s section.

Maintenance-dose monthly total (as of Oct 27, 2026)

Doses go up, and so does the drug bill. At the Wegovy pen’s regular price ($349 per month after the intro fills, as of Oct 27, 2026) and Zepbound at $449 (7.5 mg and up, only if refilled within 45 days of the prior delivery, as of Oct 27, 2026; Lilly’s regular price is $499 for 7.5 mg and $699 for 10, 12.5 and 15 mg if you refill late):

Plan + Wegovy pen $349 + Zepbound $449
Sesame, annual ($59) $408 $508
Ro, annual prepay ($74) $423 $523
WeightWatchers, 12-month ($74) $423 $523
Hims & Hers ($149) UNVERIFIED UNVERIFIED

Hims & Hers publishes no per-dose prices beyond its “from” figures, so we can’t compute its maintenance total. Sesame’s own Zepbound page lists vials at $449 for 7.5–15 mg, but lists the KwikPen at $499 for 7.5 mg and $699 for 10–15 mg. Those KwikPen figures match Lilly’s regular (late-refill) prices, so we use $449 with the 45-day refill condition from Lilly’s terms (Lilly full terms). WeightWatchers’ late-refill Zepbound prices differ from Lilly’s; see its section.

Cheapest Wegovy telehealth (pill and pen)

  • Cheapest ongoing total for the starting-dose Wegovy pill: Sesame on its annual plan, about $208/mo (as of Oct 27, 2026). Next are Ro and WeightWatchers on 12-month plans at about $223/mo. Hims & Hers is about $298/mo.
  • Cheapest without a long commitment: Sesame month-to-month, about $248/mo (as of Oct 27, 2026).
  • Wegovy pen: $199 for the first two monthly fills (0.25 mg or 0.5 mg, new patients), then $349 for any dose; Wegovy HD 7.2 mg is $399 (all as of Oct 27, 2026, per NovoCare). Ro and Sesame show the same. The intro offer runs through Dec 31, 2026.
  • Wegovy pill by dose (as of Oct 27, 2026): 1.5 mg $149, 4 mg $199, 9 and 25 mg $299. That is what both Ro’s pricing page and NovoCare’s self-pay page show. Sesame’s own pill page says $149 for 4 mg, which NovoCare doesn’t support, so use $199.
  • Cheaper-sounding headlines to treat carefully: compounded semaglutide plans advertised at $60–$99/mo (Mochi, as of Oct 27, 2026) aren’t comparable. See why we reject them.

Best telehealth for Zepbound (and the cheapest way in)

  • Zepbound starts at $299 (2.5 mg) at Ro, WeightWatchers, Sesame and Hims & Hers (as of Oct 27, 2026), so the membership decides the cheapest total: Sesame annual is about $358/mo.
  • Clearest dose-by-dose pricing: WeightWatchers and Ro list $299 / $399 / $449 (2.5 mg / 5 mg / 7.5 mg+, with refills inside 45 days; as of Oct 27, 2026), which matches Lilly’s terms. Refill late and Lilly’s regular price applies: $499 for 7.5 mg, $699 for 10, 12.5 and 15 mg. WeightWatchers’ Zepbound is dispensed through LillyDirect pharmacy.
  • Cheapest membership: Sesame. Longest lock-in: WeightWatchers.

Wegovy pill telehealth: does it work like the shot?

The Wegovy pill (25 mg) in the OASIS-4 trial produced about 13.6% average weight loss over 64 weeks counting everyone (about 30 lb from 220 lb), versus about 2.4% on placebo (about 5 lb); about 16.6% among people who stayed on treatment. Source and caveats: our drug comparison and the Novo approval release. We don’t compare it head-to-head with the pen here. For that, see Wegovy vs Zepbound and ask your clinician.

1. Sesame (Success by Sesame): 86 / 100

The short version: The cheapest membership of the ranked four, with labs usually included and plain-English refund rules, but it’s a provider marketplace, so quality depends on who you book.

The receipts (accessed Oct 27, 2026)

  • Brand vs. compounded: Not offered, per Sesame’s own pages. Its weight-loss page and its Wegovy and Foundayo pages list only FDA-approved brand products and mention no compounded option, and Sesame’s own blog post on the semaglutide shortage (updated Aug 19, 2025) says compounded semaglutide is no longer permitted under the usual rules since the shortage ended, with access “extremely limited” for new patients. Sesame did sell compounded semaglutide in 2024 (Oct 16, 2024 release).
  • Pharmacy: “Pickup or delivery” at your preferred pharmacy; for the Wegovy cash price, ask your provider to send the Rx to NovoCare Pharmacy. No single house pharmacy.
  • Clinician model: Video visits with a provider you choose. Sesame says providers on its platform set their own prices.
  • States: UNVERIFIED. The program page publishes no list of states, only that availability “may vary.” The 2024 release above said Sesame served all 50 states, but that was for compounded semaglutide, so we don’t count it for today’s brand-name program. (Labs are not included in AZ, HI, ND, NJ, NY, OK, RI, SD, WY.)
  • Insurance: Sesame doesn’t bill insurance for its care fee. Its FAQ says that if you have coverage, your provider “will work directly with your insurance” on prior authorization for the drug, and it notes Medicare and Medicaid typically don’t cover GLP-1s for weight loss.
  • Cancellation: Self-cancel any time, before the next billing cycle starts. Full refund if you cancel at least 3 hours before the first visit. Fees for past months aren’t refundable.
  • Sources: Sesame weight-loss page, Sesame Wegovy page, Sesame Wegovy pill page, Sesame Zepbound page, Sesame Foundayo page, Sesame semaglutide-shortage post, LillyDirect telehealth list, NovoCare find care.

Why it ranks here:

  • Cheapest ranked membership: $59/mo on an annual plan ($708 a year) vs. $149/mo at Hims or Ro monthly (as of Oct 27, 2026). Month-to-month is $99/mo.
  • Labs are included at Quest Diagnostics in most states, so the “membership plus labs plus meds” math stays honest.
  • Itemized medication prices that match the manufacturers (as of Oct 27, 2026): the Wegovy pill from $149, the Wegovy pen $199 for the first two months then $349 (new self-pay patients, through Dec 31, 2026), Zepbound vials and KwikPen from $299, and Foundayo from $149.
  • Third-party signal: Lilly’s find-care page lists Sesame at $99/month (as of Oct 27, 2026) with an average 1 hour to first visit (provider-reported; Lilly doesn’t endorse), and NovoCare’s find-care page lists Sesame too (Novo doesn’t endorse either).

What it costs (as of Oct 27, 2026):

  • Membership: $59/mo (12-month, billed once a year), $99/mo (month-to-month). Sesame’s page also offers 6- and 3-month plans that save $180 per 6 months and $60 per 3 months against the $99 monthly plan, which works out to about $69/mo and $79/mo (our arithmetic; Sesame doesn’t print those two monthly prices). One FAQ says the monthly plan is “billed every month at $99” and another says “billed every 28 days,” so whether you pay 12 or 13 times a year is UNVERIFIED.
  • Medication, billed separately (dose by dose, as of Oct 27, 2026):
    • Wegovy pill: 1.5 mg $149, 4 mg $199 per NovoCare (Sesame’s page says $149), 9 and 25 mg $299.
    • Wegovy pen: $199 x 2 for new patients on 0.25 or 0.5 mg, then $349 at every dose (offer through Dec 31, 2026).
    • Zepbound vial: $299 (2.5 mg), $399 (5 mg), $449 (7.5–15 mg, refilled within 45 days of the last delivery; otherwise Lilly’s regular $499 at 7.5 mg and $699 at 10–15 mg). Sesame’s page shows the KwikPen at $299 / $399 / $499 / $699, so its $499 and $699 are Lilly’s regular prices.
    • Foundayo (offer Sept 1–Dec 31, 2026): 0.8 mg $149, 2.5 mg $149, 5.5 mg $199, 9 mg $299, 14.5 and 17.2 mg $349 (or $299 under Lilly’s Journey program if you refill within 45 days).
  • The page also lists a Zepbound pen at from $1,086, far above the vial/KwikPen price. Compare before you choose a format.

The catch:

  • It’s a marketplace. Your experience depends on the clinician you pick, and we can’t score that from a web page.
  • The page says “lose up to 25% of your body weight.” That’s a ceiling claim, not an average.
  • No single named dispensing pharmacy. Read the pharmacy name on your label (see our checklist below).
  • The annual price needs a 12-month commitment.

Is Sesame legit? On its published pages we found no disqualifier: it advertises FDA-approved options, discloses refund rules, and is listed by both Lilly’s and Novo’s find-care pages. That’s not a guarantee of any one provider’s care. We didn’t test it.

Bottom line: Best value if you’re paying cash and comfortable picking your own provider. Ask your doctor whether Wegovy, Zepbound or Foundayo fits your history.

2. Ro (Ro Body): 85 / 100

The short version: The most polished all-brand program, with a named in-house pharmacy and an insurance concierge, but business-hours support and a $149/mo sticker if you don’t prepay.

The receipts (accessed Oct 27, 2026)

  • Brand vs. compounded: Its pricing page lists Wegovy pill, Wegovy pen, Zepbound KwikPen and Foundayo as “FDA-approved.” Fine print: Ro’s terms still say members “may be prescribed compounded medication during national drug shortages” and that compounded semaglutide isn’t covered by insurance. Ask in writing that every fill is brand-name.
  • Pharmacy: Roman Health Pharmacy LLC, Ro’s partner pharmacies, or a LillyDirect partner pharmacy. Prescriptions “may be transferred among the Ro Pharmacy Network without notice.”
  • Clinician model: Care comes from providers employed or contracted by Ro-affiliated physician practices (Roman Health Medical LLC is one of the listed entities). Up to 24 consults a year are included; more cost $15 each.
  • States: Ro’s own help center says it is licensed in all 50 states and D.C. but that Ro Body is not available in Hawaii, Louisiana, Mississippi or Virginia (Where is Ro available?; the page is undated). Ro’s weight-loss page publishes no state list of its own.
  • Compounded flag (no rank change): Ro’s terms, its help-center state list (“Ro Body Compounded Semaglutide”) and a Ro article on compounded semaglutide still mention compounded products, and none of them names a pharmacy for it. Its weight-loss pricing page shows only brand-name drugs, so we left Ro’s rank unchanged.
  • Labs: Included “if ordered by your health care provider.” Additional lab tests carry separate fees; amounts UNVERIFIED.
  • Cancellation: Cancel in your account or by email at least 48 hours before renewal. Paid membership fees are non-refundable. Service ends at the end of the paid cycle, and rejoining may require a new visit. $39 refunded if you’re not eligible or never prescribed medication.
  • Sources: Ro pricing, Ro terms of use (rev. Apr 2, 2026), Ro Wegovy savings release (Mar 31, 2026).

Why it ranks here:

  • Every medication line is itemized by dose and matches the manufacturer cash price (as of Oct 27, 2026): Wegovy pill $149/$199/$299, Wegovy pen $199 then $349, Wegovy HD $399, Zepbound KwikPen $299/$399/$449 ($449 is Lilly’s offer, tied to refilling within 45 days).
  • Named pharmacy: Ro names Roman Health Pharmacy LLC and says Lilly products can ship through a LillyDirect partner pharmacy.
  • Insurance help for the pens: an insurance concierge checks coverage for Ozempic, Wegovy and Zepbound autoinjector pens. The membership itself is cash-only.
  • Low-risk first month: $39 to start, refunded if you’re ineligible (as of Oct 27, 2026).

What it costs (as of Oct 27, 2026):

  • Membership (Ro’s pricing page, as of Oct 27, 2026): $74/mo (12-month, prepaid annually; Ro says it saves $900/yr), $89/mo (6-month, prepaid every 6 months; saves $720/yr), $99/mo (3-month, prepaid every 3 months; saves $600/yr), $149/mo (monthly). Ro’s page also offers a free insurance check, and its concierge handles the paperwork if your plan might cover Ozempic, Wegovy or Zepbound pens.
  • Medication: separate, as above; Wegovy and Foundayo starters $149.
  • First-year membership on annual prepay: $888. On monthly billing: $1,678.

The catch:

  • Business-hours care: terms say medical care is available Mon–Fri, 9 a.m.–6 p.m. ET, and providers review messages within 48 hours. It’s not an on-call service.
  • $149/mo monthly is the priciest ongoing membership of the ranked four (tied with Hims & Hers).
  • Compounded-during-shortage language remains in the terms (see receipts).
  • Prescriptions can move between pharmacies in the network without notice, so check the label each time.
  • Terms include mandatory binding arbitration with a 30-day opt-out.

Is Ro legit? On its published pages: named pharmacy, itemized brand-name pricing, a clear refund of the first month if you’re ineligible. Its terms also allow compounded medication during shortages. We found no disqualifier, but we didn’t test care. A third-party report cited in our research found no FDA warning letter for Ro; we did not verify that (UNVERIFIED).

Bottom line: A strong pick if you want brand-name meds, a real pharmacy name and insurance help, and you’ll prepay to cut the membership. Ask your doctor which drug and dose to start with.

3. WeightWatchers Med+ (WW Clinic): 84 / 100

The short version: The most explicit “FDA-approved only” promise of the group, but you’re signing a 6- or 12-month commitment that renews on its own.

The receipts (accessed Oct 27, 2026)

  • Brand vs. compounded: “We only prescribe FDA-approved medications.” Named GLP-1s: Wegovy, Saxenda, Zepbound; plus non-GLP-1 options (metformin, naltrexone/bupropion).
  • Pharmacy: Zepbound vials and KwikPens are “dispensed and purchased through LillyDirect pharmacy.” Oral non-GLP-1 kits ship from Carepoint (9 Commerce Dr, Schaumburg, IL). Other prescriptions go to “the pharmacy of your choice”; WW’s terms say some cash-pay drugs may be available at the stated price only through its preferred pharmacy. The pharmacy for cash-pay Wegovy is UNVERIFIED.
  • Clinician model: Medical services come through the affiliated medical group, WeightWatchers Clinic, with a “board-certified Clinician.” Some states require a live synchronous video visit.
  • States: WW’s plan-finder asks “Do you live in one of the 50 U.S. states or D.C.?” and says WW clinicians aren’t available in U.S. territories (WW supported-states page). That points to nationwide service, but WW publishes no per-state list or exceptions, and its terms say some states need a live video visit. Per-state availability is UNVERIFIED.
  • Cancellation: Cancel before the end of your commitment period; it takes effect at the end of the term. Fees are non-refundable once a period starts, except a medical-reason cancellation (unused portion refunded, minus upfront fees). No refund if your medication is unavailable.
  • Sources: WW Med+ page, WW self-pay page, WW Zepbound page, WW Clinic terms, WW Wegovy cost post.

Why it ranks here:

  • Cleanest label promise of the four (FDA-approved only, stated on the page).
  • Zepbound pricing is laid out dose by dose (as of Oct 27, 2026), including what happens if you refill late: $299 (2.5 mg), $399 (5 mg), then $449 at 7.5–15 mg if you refill within 45 days. Those three match Lilly’s terms; the late-refill column doesn’t (see the catch below).
  • Insurance coordinator handles prior authorizations, per WW, but only for commercial plans: WW says it can’t help members with government insurance, Kaiser or no insurance, who pay cash instead (WW Zepbound page). Zepbound vials and KwikPens are cash-only through LillyDirect.
  • Outcome claims are labeled as company data: WW reports that among 3,250 WW Clinic patients prescribed a GLP-1, average loss was 21% at 12 months (about 46 lb from 220 lb). That’s WW’s own analysis, not a trial.

What it costs (as of Oct 27, 2026):

  • Membership: $25 first month, then $74/mo (12-month) or $84/mo (6-month). A $49/mo 12-month cash-pay promo is on offer but ends Nov 2, 2026, and it’s for new or rejoining Med+ members who pay cash for medication (WW self-pay page, “Offer ends 11/02/26”). The fine print says the plan auto-renews for another 12 months “at the same monthly rate”; it doesn’t say whether that means $49 or the standard $74, so the renewal rate is unclear; ask before you enroll. First-year on the 12-month plan at $74: $839.
  • Medication: oral GLP-1s $149–$299 (offer through Dec 31, 2026); Zepbound as above; Wegovy pen $349/mo after intro pricing, with prepaid options of $249/$299/$329 per month for 12/6/3 months (WW’s blog, through Dec 31, 2026).

The catch:

  • Auto-renewing commitment: plans auto-renew for another term at the same monthly rate unless canceled. Cancellation lands at term end. That’s the tightest lock-in of the four.
  • Late-refill Zepbound prices don’t match Lilly’s. WW’s Zepbound page lists $599 (7.5 mg), $699 (10 mg), $849 (12.5 mg) and $1,049 (15 mg) if you refill more than 45 days after your last delivery. Lilly’s current terms say $499 (7.5 mg) and $699 (10, 12.5 and 15 mg) (Lilly Zepbound page, full terms). Only the 10 mg price agrees. WW says its Zepbound is bought through LillyDirect pharmacy, so Lilly’s terms are the baseline we use, and our drug guide already carries Lilly’s figures. What WW actually bills on a late refill isn’t confirmed: ask before you let a refill slip past 45 days. We read Lilly’s pages through search-engine excerpts because Lilly’s site blocked our direct fetch; a third-party review and Sesame’s own Zepbound page show the same $499/$699 regular prices.
  • Fees stay non-refundable even if the pharmacy can’t supply the drug.
  • Success stats are self-reported and company-run.

Bottom line: Good if you want the strictest brand-only promise and some behavioral coaching, and you’re sure you’ll stay 6–12 months. Ask your doctor about the commitment and any alternatives.

4. Hims & Hers: 78 / 100

The short version: A real pivot to brand-name drugs since March 2026 and the most convenient app, but the highest monthly membership, a 2025 FDA warning letter on its compounded marketing, and compounded semaglutide is still on the menu “if clinically necessary.”

The FDA warning letter, plainly: On Sept 9, 2025, FDA sent Hims & Hers Health, Inc. (dba Hims) a warning letter (MARCS-CMS 716567). FDA had reviewed hims.com in August 2025 and said claims for its compounded semaglutide (“Same active ingredient as Ozempic and Wegovy” and “Clinically proven ingredients”) were false or misleading, because compounded drugs are not FDA-approved and the claims implied sameness. The letter is about marketing claims. It does not say any specific product was unsafe. Hims & Hers then announced on Mar 9, 2026 that it would stop advertising compounded GLP-1s. Whether FDA has closed out the letter, and whether Hims & Hers was among FDA’s 30 telehealth letters of Mar 3, 2026: both UNVERIFIED (we didn’t find a close-out notice in the sources we could open). We scored what its pages say today, and we flag the letter so you can weigh it yourself.

The receipts (accessed Oct 27, 2026)

  • Brand vs. compounded: Per its March 9, 2026 release, Hims & Hers said it would stop advertising compounded GLP-1s and offer compounded semaglutide only on a limited scale when a provider decides it is clinically necessary. Its pricing pages now list Wegovy, Zepbound and Foundayo.
  • Pharmacy: Wegovy through NovoCare Pharmacy; Zepbound vials/KwikPen and Foundayo through LillyDirect pharmacy (Hims & Novo release, Hims LillyDirect release). Pharmacy for any compounded product: UNVERIFIED.
  • Clinician model: Licensed providers make an independent clinical decision; the page promises 24/7 care-team messaging. Depending on state, treatment may be determined without a video visit. Hims & Hers says it is not affiliated with Lilly.
  • States: Hims’ weight-loss pages say “Not available in all 50 states,” and its general help article says Hims & Hers is available in all 50 states but “specific treatments may be limited to certain states” (updated Oct 13, 2026, via search excerpt). We found no state list for its weight-loss program, so which states get which GLP-1 is UNVERIFIED. A separate help article lists eligible states for its compounded semaglutide (article, search excerpt, undated), which confirms a compounded product still has its own state rules.
  • Insurance: cash-pay only, per Hims’ own pages. Its help article, updated Feb 16, 2026, says it is “currently unable to accept insurance,” and its weight-loss FAQ says insurance “isn’t required.” We found no Hims page that says it bills insurance. A third-party review we saw claimed it bills commercial insurance; Hims’ own pages don’t support that, so we don’t count it (UNVERIFIED). FSA/HSA: the same article says the medication is eligible for FSA/HSA reimbursement, and the pricing-page FAQ says the membership fee is not. An older help page (June 2024) said Hims didn’t take FSA/HSA; the Feb 2026 article supersedes it.
  • Cancellation: Turn off auto-renew in the app or on the website. Canceling the membership also cancels your meds. You keep access to the end of the current billing period (Hims support, updated Oct 20, 2026). A search excerpt of Hers’ FAQ/terms says to cancel two days before renewal and that the first month isn’t refundable; we couldn’t open those pages (403), so treat those details as UNVERIFIED.
  • Sources: Hims pricing, Hims weight loss, Hims Wegovy pen, Hers weight loss, Hims & Novo Nordisk release (Mar 26, 2026).

Why it ranks here:

  • Brand-first now: medication list includes Wegovy pill from $149, Wegovy pen from $199, Zepbound vial and KwikPen from $299, Foundayo from $149 (all as of Oct 27, 2026), all through manufacturer pharmacies.
  • Clear that membership is separate: the page says membership does not include or guarantee a prescription, and medication isn’t available without it.
  • Easy to cancel in-app, and the medication portion is FSA/HSA-eligible.
  • Extras in the $149: 24/7 care-team messaging, nutrition guidance, and an opt-in smart scale (valued at $55 by Hims, shipped separately).

What it costs (as of Oct 27, 2026):

  • Membership: $39 first month, then $149/mo (auto-renews). We found no cheaper multi-month option; UNVERIFIED if one exists. First-year membership: $1,678. The membership is not FSA/HSA eligible.
  • Medication “from” prices (they apply to the lowest dose): $149 (Wegovy pill, Foundayo), $199 (Wegovy pen; Ozempic is diabetes-labeled), $299 (Zepbound). The same page lists Mounjaro at $1,899/mo, a diabetes-labeled drug, so don’t mistake it for the Zepbound price.

The catch:

  • Highest ongoing membership of the ranked providers, with no discount path we could find.
  • Compounded isn’t gone, just de-advertised. Ask your provider which product is on your prescription.
  • The 2025 FDA warning letter, above.
  • Membership cancel = medication cancel, so time it around shipments.
  • Its weight-loss state list and the pharmacy behind any compounded product are unverified.

Bottom line: Convenient and now brand-first, but you pay for convenience at $149/mo. Ask your doctor to confirm brand name, dose and pharmacy before you pay.

Ro vs Hims & Hers vs Sesame vs WeightWatchers: side by side

Sesame Ro WeightWatchers Med+ Hims & Hers
Membership (as of Oct 27, 2026) $59 annual / $99 monthly $74 annual prepay / $149 monthly $74 (12-mo) / $84 (6-mo) $149 monthly
First month (as of Oct 27, 2026) None advertised $39 (refunded if ineligible) $25 $39 (non-refundable per a search excerpt; UNVERIFIED)
Wegovy pill, starter (as of Oct 27, 2026) from $149 $149 from $149 (oral GLP-1s) from $149
Zepbound, starter (as of Oct 27, 2026) from $299 $299 $299 from $299
Labs Included except 9 states Included if ordered; extras UNVERIFIED UNVERIFIED UNVERIFIED
Named pharmacy None (your choice; NovoCare on request) Roman Health Pharmacy or partner LillyDirect (Zepbound); Carepoint (non-GLP-1 kits) NovoCare (Wegovy); LillyDirect (Zepbound, Foundayo)
Compounded? Not offered, per Sesame’s own pages (sold compounded in 2024) Still mentioned in Ro’s terms, help center and a Ro article; no pharmacy named (flag; no rank change) “FDA-approved only” Limited, if “clinically necessary”
Commitment None monthly; 12-mo for $59 48-hour pre-renewal notice 6 or 12 months, auto-renews Auto-renews monthly

Ro vs Hims & Hers

  • Same drugs, same medication prices (Wegovy pill from $149, Wegovy pen $199 intro, Zepbound from $299; as of Oct 27, 2026).
  • Membership: Ro $74/mo annual prepay or $149/mo monthly; Hims & Hers $149/mo with no prepaid option we found. On monthly billing they tie. On annual prepay, Ro is $75/mo cheaper (our arithmetic; as of Oct 27, 2026).
  • Starting-dose Wegovy pill total: about $223/mo at Ro on annual prepay vs. about $298/mo at Hims & Hers.
  • Compounded: Ro’s terms, help center and a Ro article still mention compounded semaglutide (no pharmacy named); Hims & Hers offers it in limited cases and got an FDA warning letter in Sept 2025 over compounded-semaglutide marketing claims.
  • Support: Ro’s care team is Mon–Fri 9–6 ET with 48-hour message review; Hims & Hers promises 24/7 messaging.
  • Insurance: Ro offers a free coverage check for pens; Hims & Hers says it can’t accept insurance (its help article, updated Feb 16, 2026).

WeightWatchers vs Ro

  • Price: both $74/mo on a 12-month plan (as of Oct 27, 2026), so starting-dose Wegovy pill totals match at about $223/mo.
  • Lock-in: WeightWatchers requires 6- or 12-month commitments that auto-renew; Ro’s cancel-by-48-hours is far looser (but paid fees are non-refundable).
  • Labels: WeightWatchers says FDA-approved only; Ro’s terms still allow compounded during shortages.
  • First month: WeightWatchers $25; Ro $39 (refunded if ineligible).
  • Promo: WeightWatchers’ $49/mo cash-pay offer on the 12-month plan ends Nov 2, 2026.

Sesame vs the rest

  • Cheapest membership ($59 annual), with labs included in most states.
  • No single pharmacy name and a marketplace clinician model, so the weakest “who exactly is dispensing and treating me” answer of the four.

Providers we disqualified: Found, Noom Med and Mochi

Each last checked on its own pages Oct 27, 2026 (we re-confirmed the Found, Noom and Mochi prices below that day). Scores are shown for reference only. Each was removed under the hard disqualifiers above. We link their pages only as sources, never as signup links.

Why Found (Found Health) didn’t make the list — 52 / 100 before disqualification

The short version: The cheapest headline price on the page ($99–$169/mo) buys compounded drugs, while the same page borrows Wegovy and Zepbound trial results.

Why it’s disqualified:

  • Compounded is the default: the plan marketed from $99/mo with insurance or $169/mo cash (as of Oct 27, 2026) includes compounded GLP-1 medication (the page lists it as a “Compounded GLP-1 Plan”). The brand-name plan bills the drug separately.
  • Brand names sit next to a compounded-first plan: its homepage headlines “Up to 15–20% weight loss with Wegovy® and Zepbound®*” next to “Plans from $99/mo… medication included on compounded plans.”
  • Compounding pharmacy not named: terms say compounded GLP-1s are filled through a “pharmacy facilitated by Found.”

The receipts (accessed Oct 27, 2026; all prices as of Oct 27, 2026)

  • Compounded pricing (all-in, billed every 28 days; re-checked Oct 27, 2026): semaglutide $289/mo (1-month cash) down to $169/mo (12-month cash); tirzepatide $359/mo down to $239/mo. Insurance track: $199→$99 and $289→$179.
  • Branded plan: $149/mo (1-month cash) down to $99/mo (12-month), medication billed separately.
  • Brand price shown on the plans page: Wegovy and Zepbound “from $650/mo+”, far above the manufacturer cash prices ($199–$349 and $299–$449 as of Oct 27, 2026) that you can reach via NovoCare or LillyDirect; Found’s plans page says brand drugs can be filled through those.
  • Labs: not included. Refunds: full refund within 3 days or before the first consult; renewals are non-refundable (cancel at least 48 hours before renewal).
  • Honest points: Found does say compounded drugs “are not FDA-approved or evaluated for safety or efficacy,” and labels its plans “compounded” in its terms.
  • States: Compounded drugs are “not available in all states” per its terms; state list UNVERIFIED.
  • Sources: Found plans, Found offer terms, Found home.

Bottom line: If you go brand-name, the manufacturer prices are much lower than the “from $650” shown here. Ask your doctor about FDA-approved options first.

Why Noom Med didn’t make the list — 50 / 100 before disqualification (borderline: disclosure is in footnotes)

The short version: The all-inclusive “GLP-1 Rx” cards don’t name the drug on the card; fine print says “not reviewed by FDA.”

Why it’s disqualified:

  • Default funnel to compounded: the headline all-inclusive plans bundle clinical care, medication and the app. Footnotes say compounded medications, “if prescribed, are not reviewed by FDA for safety, efficacy or quality,” and that Noom has “no affiliation with Novo Nordisk Inc., the only US source of FDA-approved semaglutide.”
  • Brand names are advertised elsewhere on the same site (separate Wegovy and Zepbound pages).
  • No named dispensing pharmacy on the pages we read.
  • What Noom gets right: it doesn’t claim these products are FDA-approved or generic, and the disclosure exists, just in small print.

The receipts (accessed Oct 27, 2026; all prices as of Oct 27, 2026)

  • All-inclusive plans: GLP-1 Rx $129 to start then $249/mo; Plus $149 then $299/mo; Microdose $79 then $179/mo; all billed quarterly (Noom pricing page). Noom’s own cost blog (updated Sep 22, 2026) still lists the first at $279/mo, a conflict inside Noom’s own pages. The pricing page is the one that shows $249/mo today, but we can’t tell which is right, so treat both as UNVERIFIED.
  • Branded track: $39 to start, then $129/mo for care; medication not included. Zepbound vials from $299/mo via LillyDirect (Noom Zepbound page). A search excerpt of Noom’s Wegovy page cites $1,200–$1,350/mo without insurance; we couldn’t open the full page, so whether it also shows NovoCare self-pay pricing is UNVERIFIED.
  • States: “Not available in all 50 states”; list UNVERIFIED. Cancellation/refund terms: UNVERIFIED.
  • Sources: Noom pricing, Noom Med, Noom cost blog.

Bottom line: Only the branded track is a conventional telehealth fit, and at $129/mo plus drug it’s pricier than Sesame or Ro. Ask your doctor which product you’d be prescribed.

Why Mochi Health didn’t make the list — 50 / 100 before disqualification

The short version: Rock-bottom compounded prices, a long list of compounded products (including one for which an FDA-approved version now exists), and brand names in the hero text.

Why it’s disqualified:

  • Default funnel to compounded: its price headlines are compounded. The Aug 15, 2026 pricing post (updated Sep 18) advertises compounded semaglutide at $60–$99/mo and compounded tirzepatide $90–$199/mo by dose (as of Oct 27, 2026).
  • Brand names up top: the homepage lists brand Wegovy, Wegovy pill, Zepbound and Foundayo alongside compounded tirzepatide, compounded semaglutide (injectable and oral) and compounded orforglipron. Foundayo (orforglipron) is the FDA-approved brand, and FDA says compounded drugs are not FDA-approved and not the same as generics. We did not verify FDA’s position on compounded orforglipron specifically, so its legal status is UNVERIFIED; we treat it as a red flag.
  • Pharmacy not named: no pharmacy is named on the pages we read; the pricing post refers only to “the same pharmacies.”

The receipts (accessed Oct 27, 2026; all prices as of Oct 27, 2026)

  • Membership: $79/mo, or $49/mo for as long as you stay on a 12-month plan; the homepage shows a $0 first month on the 1-month plan for new subscribers (“promotional pricing not available in all states”). Its Aug 15 pricing blog said $39 for the first month; we go with the homepage, but the blog is older, so treat the first-month price as UNVERIFIED. With qualifying insurance the homepage lists membership from $17/mo. Meds and labs (from $26) aren’t included.
  • Brand prices: the homepage lists Wegovy, Zepbound and Foundayo and a “self-pay, from $31” medication line without naming the drug, so brand-name prices are UNVERIFIED.
  • Clinician model: board-certified providers at independent, affiliated practices.
  • Cancellation: “Cancel anytime” on the homepage; refund terms UNVERIFIED.
  • Sources: Mochi per-dose pricing post, Mochi homepage.

Bottom line: Transparent per-dose pricing doesn’t offset a compounded-first model. Ask your doctor about FDA-approved options and their price paths.

Not ranked: Calibrate, manufacturer paths and visit-based telehealth

  • Calibrate: announced on Feb 19, 2026 that it had completed its move from direct-to-consumer to employers, health plans and channel partners, with about 90% of business now enterprise (press release). Whether individuals can still enroll directly is UNVERIFIED, so we didn’t score it.
  • NovoCare and LillyDirect aren’t clinics, but they’re our price baseline (NovoCare find care, LillyDirect obesity telehealth). Both link to independent telehealth options and say they don’t endorse them.
  • Provider-reported visit rates on Lilly’s page (as of Oct 27, 2026; not verified on the providers’ own sites, so UNVERIFIED): Counsel Health $29/visit (self-pay; $25/mo annual); General Medicine $25/visit average with insurance (self-pay $30 per chat visit); knownwell $31/visit average with insurance (self-pay $299/visit); Sesame $99/month. Lilly’s own pages disagree on General Medicine’s self-pay price ($30 on one, $100 on another). Pay-per-visit can beat a membership if you only need a prescription and a few check-ins, but we haven’t scored them.

Brand-name vs compounded GLP-1s

  • Brand-name (Wegovy, Zepbound, Foundayo and others) means an FDA-approved product. See our FDA-approved GLP-1 drugs comparison.
  • Compounded versions are not FDA-approved and not the same as generic drugs, per FDA’s March 3, 2026 announcement. That release announced warning letters to 30 telehealth companies over claims implying sameness with approved products and over obscuring where a product comes from.
  • Is compounded semaglutide safe? FDA’s page on unapproved GLP-1s counted 990 adverse-event reports for compounded semaglutide and more than 730 for compounded tirzepatide as of May 31, 2026. We don’t recommend or rank compounded sources. Talk with a clinician; learn the red flags in our safe-fill guide.
  • Why this decides our ranking: a rock-bottom price that depends on an unapproved compound is a risk signal, not a win. That’s why Found, Noom Med and Mochi are out, and why Hims & Hers’ limited compounded offering and 2025 warning letter are flagged.

How to pick: insurance, budget, oral vs injection, clinician style

  • Insurance: If you want your plan to pay for the drug, start with Ro (coverage check for pens) or WeightWatchers (insurance coordinator). Sesame doesn’t bill insurance for care but its providers help with prior authorization. Hims & Hers says it can’t accept insurance.
  • Budget: For the lowest first-year membership, Sesame annual ($708) beats WeightWatchers ($839) and Ro annual ($888). Hims & Hers monthly is $1,678 (as of Oct 27, 2026).
  • Oral vs. injection: All four list the Wegovy pill, and Zepbound is a weekly injection. For differences, read Wegovy vs Zepbound, then ask your clinician. New here? Our sister site’s getting-started hub is a good next click.
  • Clinician style: Sesame = pick your own provider; Ro = Ro-affiliated practices with business-hours care; Hims & Hers = independent providers with 24/7 messaging; WeightWatchers = affiliated medical group with coaching.

How to compare a live offer today

  1. Screenshot the checkout math: membership + medication + labs, for the first month and month 12.
  2. Ask for three things in writing: the brand name, the dose, and the pharmacy name that will be on your label.
  3. Check the medication line against NovoCare and LillyDirect self-pay prices in our cost guide. Same drug, same price is normal; “from $650” for a brand that costs $199–$349 direct is not.
  4. Read the cancellation clause before you pay. Look for commitment length, auto-renew, the cancellation cutoff (48 hours is common among these providers), and whether fees refund.
  5. If the only way to hit a rock-bottom price is an unapproved compound, treat that as a risk signal, not a win.
  6. Confirm your state is covered before the intake form, since several providers don’t publish a state list.

Frequently asked questions

What is the best telehealth service for GLP-1 medication? It depends on whether you want the lowest cost, the strictest brand-only promise, or insurance help. On our scorecard, Sesame (86), Ro (85) and WeightWatchers Med+ (84) are a near-tie, and Hims & Hers (78) is fourth. Pick on membership price, insurance and cancellation terms. Scores and sources are above. (Our scorecard, captured Oct 27, 2026; see methodology.)

How much does a GLP-1 telehealth program cost without insurance? Two separate bills. Membership runs from $59/mo (Sesame annual) to $149/mo (Ro or Hims & Hers monthly), and medication starts at $149 for the Wegovy pill or $299 for Zepbound (all as of Oct 27, 2026). Starting-dose totals are about $208–$298/mo for the pill. (Sources: Sesame, Ro, Hims & Hers, WeightWatchers; our arithmetic.)

Is Ro legit for GLP-1s? Is Sesame Care legit? On their published pages we found named dispensing pharmacies or manufacturer pharmacies, itemized brand-name pricing and written refund and cancellation rules, and no disqualifier. Ro’s terms still allow compounded medication during shortages, and Sesame is a marketplace of independent providers. We didn’t test either one’s care. (Sources: Ro terms, Sesame; NovoCare and Lilly list Sesame on their find-care pages.)

Is Ro cheaper than Hims & Hers for Wegovy? The Wegovy pill starter costs $149 at both (as of Oct 27, 2026). The difference is membership: Ro $74/mo on annual prepay or $149/mo monthly, vs. Hims & Hers $149/mo with no prepaid option we found. On monthly billing they tie; on annual prepay Ro is cheaper. (Sources: Ro pricing, Hims & Hers pricing.)

What is the cheapest way to get Wegovy online? By total monthly cost, Sesame’s annual plan (about $208/mo for the starting-dose pill, as of Oct 27, 2026). The Wegovy pen is $199 for the first two months, then $349. The medication price is the manufacturer’s; membership is the variable. (Sources: Sesame, Ro Wegovy savings; our arithmetic.)

Can I get a GLP-1 online without insurance? Yes, cash-pay paths exist. Hims & Hers says insurance isn’t required, and Sesame doesn’t bill insurance for its care (as of Oct 27, 2026). A prescription still requires a clinician’s approval. (Sources: Hims & Hers, Sesame.)

Do telehealth GLP-1 programs accept insurance? Mostly not for the membership. Ro’s membership is cash-only but its concierge checks coverage for the pens; WeightWatchers has an insurance coordinator for prior authorizations (commercial plans only); Sesame bills care as cash, and its providers help with prior authorization if your plan covers the drug. WeightWatchers’ coordinator only works with commercial plans. Hims & Hers says it can’t accept insurance (its help article, updated Feb 16, 2026); a third-party claim that it bills insurance isn’t supported by Hims’ pages (UNVERIFIED). Verify before you pay. (Sources: Ro pricing, WeightWatchers terms, Hims help.)

What’s the difference between brand-name and compounded semaglutide? Brand-name Wegovy is FDA-approved. Compounded drugs are not FDA-approved and not the same as generics, and FDA warned 30 telehealth companies on Mar 3, 2026 about marketing that implied sameness. (FDA.)

Why did we reject Found, Noom Med and Mochi? Each steers its cheapest plans toward compounded GLP-1s while also showing brand names, and none named a dispensing pharmacy on the pages we read. See each provider’s section above. (Sources: Found, Noom, Mochi.)

Does the Wegovy pill work as well as the injection? We don’t compare them head-to-head. In the OASIS-4 trial the 25 mg pill averaged about 13.6% weight loss over 64 weeks counting everyone, versus about 2.4% on placebo. Compare with the pen in Wegovy vs Zepbound and the drug comparison, and ask your clinician. (Novo approval release.)

How long does it take to get a prescription online? It varies by provider and state, and no provider guarantees a prescription. Lilly’s find-care page lists about 1 hour average time to first visit for Sesame (provider-reported, not time to prescription). WeightWatchers requires a live video visit in some states, and Hims & Hers says some states may not need one. (Sources: Lilly find care, WeightWatchers terms, Hims & Hers.)

Is telehealth GLP-1 prescribing safe? A licensed clinician must decide whether a prescription is appropriate for you. These medicines carry a boxed warning for thyroid C-cell tumors on their labels. Use brand-name drugs from a named pharmacy and follow our safe-fill guide. For what to expect after you start, see the side-effects hub. (FDA.)

Sources and how we’re paid

How we’re paid: See our affiliate disclosure. This page has no affiliate links today. Written by: Cora Burke. Prices last checked: October 27, 2026. Prices and offers expire; known dates: WeightWatchers $49/mo promo ends Nov 2, 2026; several medication offers end Dec 31, 2026.

Still UNVERIFIED

Item Status
States covered by Sesame, WeightWatchers (per state), Hims & Hers (weight loss), Found (cash), Noom, Mochi Still UNVERIFIED. No per-state list on the pages we read. Hims, Noom and Mochi say “not all states.” WW’s plan-finder only asks about the 50 states and D.C.; Sesame’s 2024 “all 50 states” claim was for compounded semaglutide.
Ro state availability Confirmed on Ro’s help center (undated): licensed in all 50 states and D.C.; Ro Body unavailable in HI, LA, MS and VA.
Hims & Hers insurance acceptance Resolved from Hims’ own pages: it can’t accept insurance (help article, Feb 16, 2026). A third-party claim that it bills insurance is unconfirmed and not supported by Hims.
Whether FDA closed out the Sept 9, 2025 Hims & Hers letter; whether Hims & Hers was among the Mar 3, 2026 letters Not found in the sources we could open.
FDA warning-letter check for Ro, Sesame, WeightWatchers, Found, Noom, Mochi Not done (a third-party report cited in our research found none for Ro; unconfirmed).
Dispensing pharmacy for Noom, Mochi (and Hims & Hers compounded) Not named on the pages we read.
Cash-pay Wegovy pharmacy at WeightWatchers Not named.
Sesame: Wegovy pill 4 mg price; Zepbound KwikPen vs vial prices; 3- and 6-month plan prices; monthly billing cycle Resolved with caveats. 4 mg is $199 per NovoCare (Sesame’s page says $149). Zepbound at $449 needs a refill within 45 days; Sesame’s KwikPen $499/$699 are Lilly’s regular prices. 6- and 3-month plans are derived (about $69 and $79/mo). Whether the monthly plan bills every calendar month or every 28 days is UNVERIFIED (Sesame’s FAQs disagree).
Sesame and Ro compounded semaglutide Sesame: not offered per its own pages (brand-only program pages; Aug 2025 blog says compounded is no longer permitted under the usual rules); sold it in 2024. Ro: flagged, not scored down: terms, help-center state list and a Ro article still mention compounded products and name no pharmacy; pricing page shows brand only.
Hims & Hers “cancel two days before renewal” and “first month non-refundable” Reported in a search excerpt of Hers FAQ/terms; pages blocked our fetch (403).
Hims & Hers maintenance-dose prices; multi-month discount No per-dose prices published; no multi-month discount found.
Noom cancellation and refund terms; Mochi refund terms Not captured.
Noom GLP-1 Rx price: $249/mo (pricing page) vs. $279/mo (blog) Conflict on Noom’s own pages.
Mochi first-month price ($39 blog vs. $0 homepage); Mochi brand-name prices Homepage (today) shows $0 first month for new subscribers; blog is older. Brand prices not shown (“self-pay, from $31” with no drug named). UNVERIFIED.
WeightWatchers late-refill Zepbound prices Lilly’s terms say $499 / $699 / $699 / $699 (7.5 / 10 / 12.5 / 15 mg); WW’s page says $599 / $699 / $849 / $1,049. We use Lilly’s as the baseline; what WW bills isn’t confirmed. Lilly’s pages were read through search excerpts (site blocked direct fetch).
WeightWatchers $49/mo promo renewal rate Ends Nov 2, 2026; fine print says it renews “at the same monthly rate,” not clear whether $49 or $74. Renewal rate unclear.
Ro lab test fees beyond what’s included Not published on pages we read. (Ro’s $89 and $99 tiers are now confirmed on its pricing page.)
Legal status of “compounded orforglipron” (Mochi) FDA hasn’t been seen singling it out; flagged as a red flag, not a legal finding.
Provider-reported rates on Lilly’s telehealth page Not checked against provider sites.
Hims & Hers prices Re-checked on Hims’ and Hers’ own pricing pages Oct 27, 2026 (“from” prices, $39 then $149 membership). Maintenance-dose prices still not published.
Calibrate individual enrollment Not confirmed.

Sources (all accessed October 27, 2026, America/Chicago)

Keep reading: GLP-1 cost and pricing guide · Wegovy vs Zepbound · Best FDA-approved GLP-1 drugs · How to fill a GLP-1 prescription safely · Methodology · Sister site: glp1userguide.com

Living with side effects or protein goals? See glp1userguide.com.